Godavari Drugs 38th AGM: DHDT trials done, nutraceuticals push approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs held its 38th AGM on September 25, 2026 via video conference with 86 members present. Four resolutions were tabled: adoption of FY26 financial statements, re-appointment of Mr Ghanshyam Jaju, ratification of cost auditor pay of Rs 40,000, and a special resolution to expand the main objects clause to include nutraceuticals, dietary and health supplements. Key update: DHDT anti-HIV drug intermediate trials are nearly done and commercial supplies are expected to begin shortly. Voting results to be filed within 2 working days.
Diversification into nutraceuticals signals a new growth lane. DHDT commercial supplies starting could boost near-term revenue. Procedural filing otherwise.